Hypophosphatemia had previously been linked to rhabdomyolysis, hemolysis, and respiratory and cardiac failure. In spite of the prevalence of hypophosphatemia, these clinical consequences are not ...

Learn about the symptoms and causes of hypophosphatemia. Berger MM, et al. (2020). Prevalence of hypophosphatemia in the ICU – Results of an international one-day point prevalence survey. https ...

These authors recommended parenteral therapy for all causes of hypophosphatemia, at an initial dose of 0.08 mmol/kg body weight (2.5 mg/kg body weight) if the onset was recent and the case ...

The effects of hypophosphatemia may be broad and can affect nearly every body system. Symptoms may only become apparent at serum phosphate levels below 0.32 millimoles per liter (mmol/L).

Abnormal bony projections in joint spaces and at attachments of tendons or ligaments were common among a small cohort of middle-aged adults with X-linked hypophosphatemia, progressively impairing ...

Hypophosphatemia has been implicated as a cause of rhabdomyolysis, respiratory failure, hemolysis and left ventricular dysfunction. With the exception of ventilated patients, ...

During hypophosphatemia, ATP generation could be slowed owing to a decrease in overall glycolytic rate as well as to a decrease in substrate phosphorylation at the glyceraldehyde-3-phosphate to 1 ...

There are several reasons patients with multiple myeloma may experience the electrolyte abnormality. A new literature review assessed the causes and consequences of hypophosphatemia in patients ...

Burosumab is a recombinant human IgG1 monoclonal antibody that targets FGF-23. 13,14 In phase 1 and 2 trials involving adults with X-linked hypophosphatemia, treatment with burosumab, administered ...

Hypophosphatemia affects the entire body, even on an intracellular level. If gone untreated, it can result in: Bone diseases like rickets, osteopenia, osteoporosis, and osteomalacia; ...